Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan
- PMID: 15075268
- PMCID: PMC387637
- DOI: 10.1128/EC.3.2.385-392.2004
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan
Abstract
Several genes are essential for Cryptococcus neoformans capsule synthesis, but their functions are unknown. We examined the localization of glucuronoxylomannan (GXM) in strain B-3501 and in cap59 mutants B-4131 and C536. Wild-type strain B-3501 showed a visible capsule by India ink staining and immunofluorescence with anticapsular monoclonal antibodies (MAbs) 12A1 and 18B7. B-4131, a mutant containing a missense mutation in CAP59, showed no capsule by India ink staining but revealed the presence of capsular polysaccharide on the cell surface by immunofluorescence. The cap59 gene deletion mutant (C536), however, did not show a capsule by either India ink staining or immunofluorescence. Analysis of cell lysates for GXM by enzyme-linked immunosorbent assay revealed GXM in C536 samples. Furthermore, the epitopes recognized by MAbs 12A1, 2D10, 13F1, and 18B7 were each detected in the cytoplasm of all strains by immunogold electron microscopy, although there were differences in location consistent with differences in epitope synthesis and/or transport. In addition, the cells of B-3501 and B-4131, but not those of the cap59 deletant, assimilated raffinose or urea. Hence, the missense mutation of CAP59 in B-4131 partially hampered the trafficking of GXM but allowed the secretion of enzymes involved in hydrolysis of raffinose or urea. Furthermore, the cell diameter and volume for strain C536 are higher than those for strain B-3501 or B-4131 and may suggest the accumulation of cellular material in the cytoplasm. Our results suggest that CAP59 is involved in capsule synthesis by participating in the process of GXM (polysaccharide) export.
Figures





Similar articles
-
Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.Eukaryot Cell. 2009 Aug;8(8):1165-73. doi: 10.1128/EC.00013-09. Epub 2009 Jun 19. Eukaryot Cell. 2009. PMID: 19542308 Free PMC article.
-
Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans.Mol Cell Probes. 1989 Dec;3(4):345-61. doi: 10.1016/0890-8508(89)90014-5. Mol Cell Probes. 1989. PMID: 2482437
-
Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.Med Mycol. 1999 Aug;37(4):235-43. Med Mycol. 1999. PMID: 10421858
-
The Overlooked Glycan Components of the Cryptococcus Capsule.Curr Top Microbiol Immunol. 2019;422:31-43. doi: 10.1007/82_2018_140. Curr Top Microbiol Immunol. 2019. PMID: 30203395 Review.
-
Microreview: capsule-associated genes of Cryptococcus neoformans.Mycopathologia. 2007 Jan;163(1):1-8. doi: 10.1007/s11046-006-0083-0. Mycopathologia. 2007. PMID: 17216326 Review.
Cited by
-
Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier.Am J Pathol. 2005 Feb;166(2):421-32. doi: 10.1016/S0002-9440(10)62265-1. Am J Pathol. 2005. PMID: 15681826 Free PMC article.
-
Cryptococcus neoformans Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model.mBio. 2019 Apr 2;10(2):e02909-18. doi: 10.1128/mBio.02909-18. mBio. 2019. PMID: 30940711 Free PMC article.
-
Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe.J Biol Chem. 2020 Mar 27;295(13):4327-4340. doi: 10.1074/jbc.RA119.012251. Epub 2020 Jan 31. J Biol Chem. 2020. PMID: 32005661 Free PMC article.
-
The buoyancy of cryptococcal cells and its implications for transport and persistence of Cryptococcus in aqueous environments.mSphere. 2024 Dec 19;9(12):e0084824. doi: 10.1128/msphere.00848-24. Epub 2024 Nov 27. mSphere. 2024. PMID: 39601568 Free PMC article.
-
The Cryptococcus neoformans capsule: lessons from the use of optical tweezers and other biophysical tools.Front Microbiol. 2015 Jun 24;6:640. doi: 10.3389/fmicb.2015.00640. eCollection 2015. Front Microbiol. 2015. PMID: 26157436 Free PMC article. Review.
References
-
- Casadevall, A., W. Cleare, M. Feldmesser, A. Glatman-Freedman, D. L. Goldman, T. R. Kozel, N. Lendvai, J. Mukherjee, L. A. Pirofski, J. Rivera, A. L. Rosas, M. D. Scharff, P. Valadon, K. Westin, and Z. Zhong. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446. - PMC - PubMed
-
- Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154:27-35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources